| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/01/2005 | WO2005030967A3 Crop plant cystatin proteinase inhibitors and methods of use |
| 09/01/2005 | WO2005024426A3 HIGH-THROUGHPUT-ASSAY WITH HIGH SENSITIVITY FOR MEASURING OF THE ACTIVITY OF β-ADRENERGIC RECEPTOR KINASE AND FOR DETERMINING THE IMPACT OF TEST SUBSTANCES ON SUCH ACTIVITY |
| 09/01/2005 | WO2005004792A3 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 09/01/2005 | WO2004098282A3 Nematode atp synthase subunit e-like sequences |
| 09/01/2005 | WO2004087750A3 A method for oxygen regulated production of recombinant staphylokinase |
| 09/01/2005 | WO2004072282A9 Nephropathy-associated gene |
| 09/01/2005 | WO2004067718A3 Necrosis-deficient mutants of tuberculosis bacteria |
| 09/01/2005 | WO2004056310A3 Methods of diagnosis and treatment of interstitial lung disease |
| 09/01/2005 | WO2004048520A3 Redd1, a transcriptional target of p63 and p53, and methods of use therefor |
| 09/01/2005 | WO2004048512A3 Novel proteins and nucleic acids encoding same |
| 09/01/2005 | WO2004044553A3 Lepidoptera voltage-gated calcium channels |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2004020405A3 Modified transferrin fusion proteins |
| 09/01/2005 | WO2004008099A3 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 09/01/2005 | WO2004003140A3 Cytokine receptor zcytor17 multimers |
| 09/01/2005 | WO2003104399A3 Cancer-linked gene as target for chemotherapy |
| 09/01/2005 | WO2003089574A3 Synthetic glyco-lipo-peptides as vaccines |
| 09/01/2005 | WO2003013426A3 Multivalent synthetic vaccine for cancer |
| 09/01/2005 | US20050193447 Enhance drought tolerance of plant by transform with vector containing signal transduction polynucleotide sequence to produce a transgenic plant |
| 09/01/2005 | US20050193443 Using vector transformation to generate transgenic plants with enhanced resistance to drought and high environments |
| 09/01/2005 | US20050193434 IL-21 as a regulator of immunoglobin production |
| 09/01/2005 | US20050193433 Using nuclear receptor to identify modulators for controlling intestinal cholesterol adsorption |
| 09/01/2005 | US20050193431 Somatic cell line |
| 09/01/2005 | US20050192428 Modified procollagen comprising collagen peptide chain and site-specific proteolytic agent recognition site for use preparation of biodegradable surical materials |
| 09/01/2005 | US20050192427 Novel death domain proteins |
| 09/01/2005 | US20050192239 Methods for identifying risk of breast cancer and treatments thereof |
| 09/01/2005 | US20050192224 Modulation platelet adhesion based on the surface-exposed beta-switch loop of platelet glycoprotein IB-alpha |
| 09/01/2005 | US20050192219 Therapies involving mutated heat shock transcription factor |
| 09/01/2005 | US20050192215 Methods and materials relating to novel polypeptides and polynucleotides |
| 09/01/2005 | US20050192211 Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 09/01/2005 | US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system |
| 09/01/2005 | US20050191737 Carcinostatic agent |
| 09/01/2005 | US20050191736 Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same |
| 09/01/2005 | US20050191732 Vector comprising nucleotide sequences coding homeostasis and adaptation (HA) proteins for use in enhancing/improving heterologous gene expression |
| 09/01/2005 | US20050191730 IL-4/IL-13 specific polypeptides and therapeutic uses thereof |
| 09/01/2005 | US20050191729 Methods for the recombinant production of antifusogenic peptides |
| 09/01/2005 | US20050191728 Connecting peptides (mini C-peptides) which confer an increased production yield in insulin derivatives when expressed in a transformed microorganism |
| 09/01/2005 | US20050191725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/01/2005 | US20050191724 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 09/01/2005 | US20050191722 Streptavidin-binding peptides and uses thereof |
| 09/01/2005 | US20050191721 Tim-3 (t cell immunoglobulin and mucin domain containing molecule) polypeptide for use in enhancement of immune and transplantaion tolerance |
| 09/01/2005 | US20050191720 A vector for the surface expression of antibiotics composed of one or more genes that encode the synthetase and a gene encoding an amphiphilic peptide antibiotic having antibacterial, antifungal and anticancer activities; lactic acid-forming bacteria transformed with the vector |
| 09/01/2005 | US20050191719 Using adenosine triphosphatase as tool for detecting modulators of immune response |
| 09/01/2005 | US20050191712 immunoassay of acidic repeat protein/immunogens; solid phase synthesis; kits for diagnosis of syphilis |
| 09/01/2005 | US20050191711 Cerebral amyloid plaque precursors for use as diagnostic tool in detection of nervous system disorders |
| 09/01/2005 | US20050191710 Method for labeling a membrane-localized protein |
| 09/01/2005 | US20050191706 Biological scaffold comprising src, major histocompatibility and/or pdz domains for use as diagnostic tool in detection of metabolic disorders |
| 09/01/2005 | US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 09/01/2005 | US20050191702 Immunoglobulin comprising chemokine receptor binding domain and T cell surface polypeptide for use in prevention and treatment of nervous system, skin, diabetes, graft versus host, inflammatory joint and autoimmune diseases |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191688 Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| 09/01/2005 | US20050191681 Nucleotide sequences coding secretory proteins for use in diagnosis, prevention and treatment of nervous system, inflammatory, cell proliferative, cardiovascular and blood disorders |
| 09/01/2005 | US20050191680 Therapeutic nucleic acid-3' -conjugates |
| 09/01/2005 | US20050191673 Nucleotide sequences coding tumor marker genes for use as tool in classification, diagnosis and prognosis of cell proliferative disorders |
| 09/01/2005 | US20050191671 Transport protein peptide related to sodium/hydrogen exchanger-regulatory factors for use in identifying modulators for prevention and treatment of nervous system and cell proliferative disorders; antiproliferative agents |
| 09/01/2005 | US20050191662 Peptide nucleic acid fusion for use in cell-free translation systems |
| 09/01/2005 | US20050191661 Treatment of inflammatory disease by cleaving TNF receptors |
| 09/01/2005 | US20050191659 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 09/01/2005 | US20050191658 Allelic series of genomic modifications in cells |
| 09/01/2005 | US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders |
| 09/01/2005 | US20050191645 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/01/2005 | US20050191639 Method to isolate genes involved in aging |
| 09/01/2005 | US20050191635 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
| 09/01/2005 | US20050191633 Isolated from Bacillus substilus; immunogens; solid phase synthesis; reverse transcription; kits |
| 09/01/2005 | US20050191631 Screening compounds for centromere-associated protein E (CENP-E) activity by determining plus end-directed microtubule motor activity, ATPase activity, or microtubule binding activity of a candidate compound, especially on Xenopus CENP-E |
| 09/01/2005 | US20050191628 Using bacterial models as tool in finding phage-encoded polypeptides specific for inhibition of steps in cell wall biosynthesis; small protein antibiotics; replicase inhibitors |
| 09/01/2005 | US20050191624 Novel molecules of the nbs/lrr protein family and uses thereof |
| 09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 09/01/2005 | US20050191612 Using g protein coupled receptors as tool in identifying modulators for treatment and prevention of diabetes; antidiabetic agents |
| 09/01/2005 | US20050191316 Neisseria genomic sequences and methods of their use |
| 09/01/2005 | US20050191315 Identification of epitopes on staphylococcal enterotoxins |
| 09/01/2005 | US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease |
| 09/01/2005 | US20050191312 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma |
| 09/01/2005 | US20050191307 Novel multidrug resistance-associated polypeptide |
| 09/01/2005 | US20050191304 Employing Zvegf3 antagonists |
| 09/01/2005 | US20050191303 Interleukin-18-binding protein |
| 09/01/2005 | US20050191302 Administering an inducer (sulfasalazine) of hepatic stellate cell apoptosis; selective delivery; fibrosis; inhibiting interaction of a tissue inhibitor of a matrix metalloprotease (TIMP) with a matrix metalloprotease |
| 09/01/2005 | US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 09/01/2005 | US20050191296 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof |
| 09/01/2005 | US20050191295 Receptor |
| 09/01/2005 | US20050191293 Isolated human monoclonal antibody, or an antigen-binding portion thereof; binds to human IP-10 (nterferon gamma inducible protein); cross-reacts with Rhesus monkey IP-10; inhibits calcium flux and cell migration; does not cross-react with mouse IP-10; autoimmune diseases; antiinflammatory agents |
| 09/01/2005 | US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome. |
| 09/01/2005 | US20050191287 Bioinsecticide formulation consisting of Bacillus thuringiensis var israelensis, and its concerning manufacture proceedings |
| 09/01/2005 | US20050191285 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated |
| 09/01/2005 | US20050191239 Reacting a 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid, DOTA chelating agent and a protein to form the conjugate, reacting the conjugate with a quenching agent of hydroxylamine at an alkaline pH |
| 09/01/2005 | DE102004007658A1 Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen A process for the production of recombinant proteins in eukaryotic host cells |
| 09/01/2005 | DE102004003411A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A method for producing L-amino acids using strains of the family Enterobacteriaceae |
| 09/01/2005 | CA2557725A1 Highly active glycoproteins-process conditions and an efficient method for their production |
| 09/01/2005 | CA2557424A1 Methods for protein production |
| 09/01/2005 | CA2557333A1 Antifungal peptides |
| 09/01/2005 | CA2556861A1 Protein ligands for nkg2d and ul16 receptors and uses thereof |
| 09/01/2005 | CA2556425A1 Methods of modulating il-23 activity; related reagents |
| 09/01/2005 | CA2556141A1 Method and device for detecting feline immunodeficiency virus |
| 09/01/2005 | CA2556054A1 Photoreactive compound specifically binding to calcium binding proteins |
| 09/01/2005 | CA2555972A1 Hyphal growth in fungi |
| 09/01/2005 | CA2555841A1 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 09/01/2005 | CA2555772A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 09/01/2005 | CA2555550A1 Galanin receptors and brain injury |
| 09/01/2005 | CA2555417A1 Inhibition of fgf signaling |